MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Sells 5,695 Shares of HealthEquity, Inc. $HQY

Key Points

• MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. reduced its position in HealthEquity, Inc. by 5.0%, resulting in ownership of 109,191 shares valued at approximately $9.65 million.
• Institutional investors have significantly increased their stakes in HealthEquity, with Invesco Ltd. raising its holdings by 50.6% during the 1st quarter.
• Recent analyst reports have positive ratings for HealthEquity, with a consensus average target price of $119.77, indicating a strong buy outlook.

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. decreased its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 5.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 109,191 shares of the company's stock after selling 5,695 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned 0.13% of HealthEquity worth $9,649,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Ieq Capital LLC grew its holdings in HealthEquity by 4.4% during the 1st quarter. Ieq Capital LLC now owns 2,945 shares of the company's stock worth $260,000 after acquiring an additional 123 shares during the last quarter. Xponance Inc. grew its holdings in HealthEquity by 1.1% during the 1st quarter. Xponance Inc. now owns 12,412 shares of the company's stock worth $1,097,000 after acquiring an additional 136 shares during the last quarter. Fifth Third Bancorp grew its holdings in HealthEquity by 17.5% during the 1st quarter. Fifth Third Bancorp now owns 955 shares of the company's stock worth $84,000 after acquiring an additional 142 shares during the last quarter. AlphaQ Advisors LLC grew its holdings in HealthEquity by 5.1% during the 1st quarter. AlphaQ Advisors LLC now owns 3,430 shares of the company's stock worth $303,000 after acquiring an additional 165 shares during the last quarter. Finally, State of Wyoming grew its holdings in HealthEquity by 2.9% during the 1st quarter. State of Wyoming now owns 5,915 shares of the company's stock worth $523,000 after acquiring an additional 169 shares during the last quarter. Institutional investors own 99.55% of the company's stock.

Insider Transactions at HealthEquity

In related news, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the sale, the executive vice president directly owned 53,225 shares of the company's stock, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 1.50% of the company's stock.

HealthEquity Stock Up 0.2%

NASDAQ HQY traded up $0.15 during trading hours on Friday, reaching $92.49. 616,085 shares of the company's stock were exchanged, compared to its average volume of 1,219,389. The company's 50-day moving average is $93.46 and its two-hundred day moving average is $94.50. HealthEquity, Inc. has a one year low of $74.07 and a one year high of $116.65. The company has a debt-to-equity ratio of 0.47, a quick ratio of 4.23 and a current ratio of 4.23. The company has a market capitalization of $7.97 billion, a price-to-earnings ratio of 56.05, a price-to-earnings-growth ratio of 1.32 and a beta of 0.50.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the stock. Royal Bank Of Canada increased their price objective on shares of HealthEquity from $109.00 to $110.00 and gave the stock an "outperform" rating in a report on Wednesday, September 3rd. Raymond James Financial reissued a "strong-buy" rating and set a $120.00 price objective (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. The Goldman Sachs Group increased their price objective on shares of HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a report on Wednesday, June 4th. Barrington Research reissued an "outperform" rating and set a $125.00 price objective on shares of HealthEquity in a report on Friday, August 29th. Finally, Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, HealthEquity currently has a consensus rating of "Buy" and an average price target of $119.77.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.